Young H, Carnochan P, Zweit J, Babich J, Cherry S, Ott R
Joint Department of Physics, Royal Marsden Hospital, Sutton, Surrey, UK.
Eur J Nucl Med. 1994 Apr;21(4):336-41. doi: 10.1007/BF00947969.
Copper(II)-pyruvaldehyde bis (N-4-methylthiosemicarbazone) (Cu-PTSM) labelled with 62,64Cu is a promising radiotracer for the study of blood flow using positron emission tomography (PET). We have investigated the application of a simple trapped tracer model to measurements of tissue 64Cu-PTSM uptake combined with continuous arterial sampling. A dual-tracer method was used to compare blood flow estimated by 64Cu-PTSM with values derived from measurements using cobalt-57 microspheres in the rat. Prolonged retention of 64Cu-PTSM following intravenous administration was initially confirmed in both normal tissues and tumours. After intraventricular 64Cu-PTSM infusion, cumulative arterial 64Cu activity increased progressively, and after extraction in n-octanol was found to plateau to levels corresponding with those reached following administration of 57Co microspheres. Rapid and species-dependent rates of 64Cu-PTSM decomposition to non-extractable 64Cu complexes were found in rat and human blood in vitro (70% +/- 6% and 43 +/- 5% respectively at 16 min), demonstrating the need for immediate processing of arterial samples. Close agreement was found between blood flow estimated by 64Cu-PTSM and 57Co microsphere methods in tissues of low to moderate flow: muscle (0.01, 0.08, 0.07 ml/min per gram; mean difference, mean 64Cu, mean 57Co), brain (0.09, 0.52, 0.43 ml/min per gram) and kidney (-0.16, 2.29, 2.45 ml/min per gram). Estimates of cardiac output also compared favourably between the two methods (5.7, 59.8, 54.1 ml/min). We conclude that a simple tissue trapping model may be suitable for the derivation of blood flow estimates using 62,64Cu-PTSM, PET imaging and continuous arterial blood sampling.
用⁶²Cu、⁶⁴Cu标记的铜(II)-丙酮醛双(N-4-甲基硫代半卡巴腙)(Cu-PTSM)是一种很有前景的放射性示踪剂,可用于利用正电子发射断层扫描(PET)研究血流。我们研究了一种简单的滞留示踪剂模型在结合连续动脉采样测量组织⁶⁴Cu-PTSM摄取方面的应用。采用双示踪剂方法比较了⁶⁴Cu-PTSM估计的血流与大鼠中使用钴-57微球测量得出的值。静脉注射后,在正常组织和肿瘤中最初均证实⁶⁴Cu-PTSM有长时间滞留。脑室内注入⁶⁴Cu-PTSM后,动脉血中⁶⁴Cu的累积活性逐渐增加,经正辛醇萃取后发现其稳定在与注入⁵⁷Co微球后达到的水平相对应的水平。在体外大鼠和人血液中发现⁶⁴Cu-PTSM快速且物种依赖性地分解为不可萃取的⁶⁴Cu络合物(16分钟时分别为70%±6%和43±5%),这表明需要立即处理动脉样本。在低至中等血流的组织中,⁶⁴Cu-PTSM估计的血流与⁵⁷Co微球方法之间发现密切一致:肌肉(每克0.01、0.08、0.07毫升/分钟;平均差异,平均⁶⁴Cu,平均⁵⁷Co)、脑(每克0.09、0.52、0.43毫升/分钟)和肾脏(每克-0.16、2.29、2.45毫升/分钟)。两种方法对心输出量的估计也比较吻合(5.7、59.8、54.1毫升/分钟)。我们得出结论,一个简单的组织滞留模型可能适用于使用⁶²Cu、⁶⁴Cu-PTSM、PET成像和连续动脉血采样来推导血流估计值。